<DOC>
	<DOCNO>NCT00265967</DOCNO>
	<brief_summary>Study objective : - To demonstrate effect irbesartan regulation diastolic blood pressure , case miss one dose period administration 6 8 week - To evaluate safety irbesartan</brief_summary>
	<brief_title>Irbesartan Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<criteria>Having average value ≥ 95 mmHg ≤ 109 mmHg diastolic blood pressure measurement average diastolic blood pressure value ≥ 85 mmHg 24hours arterial blood pressure measurement , Received treatment within last 3 month . Premenopausal woman least one follow condition , Not surgically sterile , Are nursing , Having childbearing potential use reasonable contraception method think continue method throughout study . Reasonable contraception method : intrauterine device , oral implantable injectable contraception method . No method accept . Patients routinely sleep within day since she/he work nightshift whose work hour continue time shift midnight 04:00 A.M . Patients average systolic blood pressure = 180 mmHg sit position average diastolic blood pressure ≥110 mmHg sit position baseline visit Having know suspected secondary hypertension Having renal and/or hepatic failure together follow laboratory criterion : Having elevate value SGPT ( ALT ) SGOT ( ALT ) ( least twice upper limit normal range ) Having serum creatinine level &gt; 2.3 mg/dL ( &gt; 203 μmol/L ) With bilateral renal artery stenosis single kidney unilateral renal artery stenosis postrenal transplantation single kidney , Having symptomatic sodium insufficiency , hypokalemia hyperkalemia , With volume deficiency , With primary hyperaldosteronism , With biliary obstructive disorder , Having congestive heart failure ( New York Heart Association ( NYHA ) functional class CHF IIIIV ) , With unstable angina pectoris occur within 3 month sign informed consent . With stroke occur within 6 month sign informed consent , With myocardial infarction cardiac surgery within three month sign informed consent , Underwent PTCA ( percutaneous transluminal coronary revascularization ) within three month sign informed consent , Having continuous tachycardia , atrial fibrillation , atrial flutter clinical arrythmias define investigator With hypertrophic obstructive cardiomyopathy , aortic stenosis , hemodynamically relate aortic mitral valve stenosis , With insulindependant diabetes mellitus whose blood sugar regulation could control within last 3 month HbA1C measurement equal 10 % . With history drug alcohol addiction within last 6 month sign informed consent , Receiving drug define protocol blood pressure regulation , Who participate investigational study within prior month sign informed consent With known hypersensitivity drug use . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>